Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2225 - 2232 of 12015 results
Update: President Biden Signs Historic Legislation Providing Expansive Clean Energy Tax Incentives
August 17, 2022| Blog| Viewpoint
Mintz Venture Watch — Volume 3: A Report on Deal Trends from Q1 and Q2 2022
August 17, 2022| Article| Viewpoint
Amendment to Delaware Law Permits Exculpation of Officers in Corporate Charters
August 15, 2022| Advisory| Viewpoint
The NLRB’s Busy July – A Harbinger of Future Coordinated Federal Action Between the NLRB, FTC, and DOJ
August 15, 2022| Blog| Viewpoint
CDC Shifts Approach and Loosens COVID-19 Quarantine Recommendations, including for Most Workplaces
August 15, 2022| Blog| Viewpoint
DOJ Crackdown on Genetic Testing Telefraud
August 15, 2022| News
'Unprecedented Times': A Power Shortage In Data Center Alley Has Developers Scrambling
August 14, 2022| News
Enforcing Patents Isn't Easier As America Invents Act Turns 10
August 12, 2022| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|